fluticasone vilanterol Breo Ellipta
Selected indexed studies
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. (N Engl J Med, 2018) [PMID:29668352]
- ** (, 2016) [PMID:28121097]
- Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD. (Med Lett Drugs Ther, 2013) [PMID:26839934]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. (2018) pubmed
- Drugs for asthma. (2024) pubmed
- Drugs for COPD. (2020) pubmed
- Drugs for COPD. (2024) pubmed
- PMID:28121097 (2016) pubmed
- Breo Ellipta: An Inhaled Fluticasone/ Vilanterol Combination for COPD. (2013) pubmed
- FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease. (2017) pubmed
- Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. (2021) pubmed
- Pharmaceutical Approval Update. (2015) pubmed
- Fluticasone furoate/vilanterol: a review of its use in patients with asthma. (2015) pubmed